Hypogonadism. female E28.39. ICD-10-CM Diagnosis Code E28.39. Other primary ovarian failure. 2016 2017 2018 2019 2020 2021 Billable/Specific Code. Applicable To. Decreased estrogen. Resistant ovary syndrome. hypogonadotropic E23.0.
Diagnosis Index entries containing back-references to E28.1: Excess, excessive, excessively androgen E28.1 (ovarian) Hypersecretion androgen (testicular) E29.0 ICD-10-CM Diagnosis Code E29.0. Testicular hyperfunction 2016 2017 2018 2019 2020 Billable/Specific Code Male Dx Increase, increased androgens E28.1 (ovarian)
Hypothyroidism, unspecified 1 E03.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2019 edition of ICD-10-CM E03.9 became effective on October 1, 2018. 3 This is the American ICD-10-CM version of E03.9 - other international versions of ICD-10 E03.9 may differ.
Diagnosis Index entries containing back-references to N95.1: Climacteric (female) - see also Menopause symptoms N95.1 (female) Flushing R23.2 ICD-10-CM Diagnosis Code R23.2 Hot flashes menopausal N95.1 Menopause, menopausal (asymptomatic) (state) Z78.0 ICD-10-CM Diagnosis Code Z78.0 Sleeplessness - see Insomnia menopausal N95.1
0.
E29. 1 - Testicular hypofunction. ICD-10-CM.
Testicular hypofunction from the age of puberty onward may lead to testosterone deficiency, infertility, or both. Such hypofunction may be primary in the testes (primary hypogonadism) or secondary to deficiency of pituitary gonadotropic hormones (secondary hypogonadism).
The 2022 edition of ICD-10-CM Z79. 890 became effective on October 1, 2021. This is the American ICD-10-CM version of Z79.
Testosterone testing is used to evaluate androgen excess or deficiency related to gonadal function, adrenal function, or tumor activity. Testosterone levels may be helpful in men for the diagnosis of hypogonadism, hypopituitarism, Klinefelter syndrome, and impotence (low values).
Two CPT codes are used for each type such as:84402: Testosterone, free.84403: Testosterone, total.
ICD-10 code E29. 1 for Testicular hypofunction is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .
Pituitary gland and hypothalamus Male hypogonadism means the testicles don't produce enough of the male sex hormone testosterone. There are two basic types of hypogonadism: Primary. This type of hypogonadism — also known as primary testicular failure — originates from a problem in the testicles. Secondary.
Hypogonadism occurs when the body's sex glands produce little or no hormones. In men, these glands (gonads) are the testes. In women, these glands are the ovaries.
890.
Group 1CodeDescription96372THERAPEUTIC, PROPHYLACTIC, OR DIAGNOSTIC INJECTION (SPECIFY SUBSTANCE OR DRUG); SUBCUTANEOUS OR INTRAMUSCULARJ1071INJECTION, TESTOSTERONE CYPIONATE, 1 MGJ3121INJECTION, TESTOSTERONE ENANTHATE, 1 MGJ3145INJECTION, TESTOSTERONE UNDECANOATE, 1 MG3 more rows
HCPCS code J1071 for Injection, testosterone cypionate, 1 mg as maintained by CMS falls under Drugs, Administered by Injection .
Clinical manifestations of hyperandrogenism include hirsutism, acne, androgenic alopecia, and virilization. Hirsutism, defined as excessive growth of terminal hair in women in a male-like pattern, is the most commonly used clinical diagnostic criterion of hyperandrogenism.
Hyperandrogenism or androgen excess is a common endocrine disorder of women of reproductive-age, with a prevalence of 5-10%. The majority of patients with hyperandrogenism will have polycystic ovary syndrome.
However, isolated presence of any of these manifestations is not used as a diagnostic criterion for hyperandrogenism.